Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 11.77
(-0.17%)
CNY 11.77
(-0.17%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 194.71 Million CNY | 17.34% |
| 2022 | 146.03 Million CNY | 8.55% |
| 2021 | 134.53 Million CNY | 22.47% |
| 2020 | 109.84 Million CNY | 36.69% |
| 2019 | 80.36 Million CNY | -8.93% |
| 2018 | 88.24 Million CNY | -9.23% |
| 2017 | 97.21 Million CNY | 21.43% |
| 2016 | 80.05 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 45.15 Million CNY | -4.57% |
| 2024 Q3 | 45.88 Million CNY | 39.6% |
| 2024 Q2 | 31.41 Million CNY | -30.42% |
| 2023 Q1 | 36.66 Million CNY | -17.42% |
| 2023 FY | 171.35 Million CNY | 17.34% |
| 2023 Q4 | 47.31 Million CNY | 4.37% |
| 2023 Q3 | 45.33 Million CNY | 7.8% |
| 2023 Q2 | 42.05 Million CNY | 14.69% |
| 2022 Q2 | 30.6 Million CNY | -15.05% |
| 2022 FY | 146.03 Million CNY | 8.55% |
| 2022 Q1 | 36.02 Million CNY | 12.36% |
| 2022 Q3 | 35.01 Million CNY | 14.41% |
| 2022 Q4 | 44.39 Million CNY | 26.8% |
| 2021 Q4 | 32.06 Million CNY | -9.67% |
| 2021 FY | 134.53 Million CNY | 22.47% |
| 2021 Q3 | 35.49 Million CNY | -0.58% |
| 2021 Q1 | 31.26 Million CNY | -24.65% |
| 2021 Q2 | 35.7 Million CNY | 14.21% |
| 2020 FY | 109.84 Million CNY | 36.69% |
| 2020 Q4 | 41.49 Million CNY | 78.04% |
| 2020 Q3 | 23.3 Million CNY | -6.87% |
| 2020 Q2 | 25.02 Million CNY | 24.93% |
| 2020 Q1 | 20.02 Million CNY | -7.13% |
| 2019 Q3 | 18.47 Million CNY | 0.0% |
| 2019 Q4 | 21.56 Million CNY | 16.75% |
| 2019 FY | 80.36 Million CNY | -8.93% |
| 2018 FY | 88.24 Million CNY | -9.23% |
| 2017 FY | 97.21 Million CNY | 21.43% |
| 2016 FY | 80.05 Million CNY | 0.0% |